Arovella Therapeutics Ltd. announced that Mr. Paul Hopper is stepping down from his role as Non-Executive Chairman on June 30, 2022. Non-Executive Director of Arovella, Dr Elizabeth Stoner will assume the role as interim Chairperson, while the company engages in a search for a replacement.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.11 AUD | +4.76% | 0.00% | -4.35% |
03-26 | Arovella Therapeutics Receives Firm Commitments for About AU$12.5 Million Raise | MT |
03-20 | Arovella Therapeutics' ALA-101-onCARlytics Collaboration with Imugene Ends; Shares Down 12% | MT |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-4.35% | 73.21M | |
+62.90% | 62.59B | |
-2.14% | 41.18B | |
+44.76% | 40.29B | |
-8.93% | 27.9B | |
+12.33% | 26.21B | |
-22.01% | 19.09B | |
+3.42% | 13.08B | |
+25.39% | 12.26B | |
+27.37% | 12.05B |
- Stock Market
- Equities
- ALA Stock
- News Arovella Therapeutics Limited
- Arovella Therapeutics Ltd Announces Executive Changes